« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 1
, Pages
68-74
, January 2006
Tumor Cell Purging by Ex Vivo Expansion of Hemopoietic Stem Cells from Breast Cancer Patients Combined with Targeting ErbB Receptors
-
Quantitation of tumor contamination on MPB harvest. Mammaglobin amplification curves on reconstitution experiments with SKBR3 cells and peripheral mononuclear cells (curves from 1 SKBR3/10 mononuclear
Quantitation of tumor contamination on MPB harvest. Mammaglobin amplification curves on reconstitution experiments with SKBR3 cells and peripheral mononuclear cells (curves from 1 SKBR3/10 mononuclear cells to 1 SKBR3/106 mononuclear cells from a healthy donor) and on 5 (from patient 1 to patient 5) MPB collections derived from breast cancer patients are shown. NTC indicates no template control. RN indicates reporter fluorescence normalized to internal control.
-
Effect of trastuzumab on cocultures of SKBR3 cells and hemopoietic precursor cells. Representative amplification curves are shown of GAPDH (control gene) and MAM (target gene) obtained by mammaglobinEffect of trastuzumab on cocultures of SKBR3 cells and hemopoietic precursor cells. Representative amplification curves are shown of GAPDH (control gene) and MAM (target gene) obtained by mammaglobin (MAM) quantitative reverse transcriptase-PCR in coculture of SKBR3 tumor cells and normal progenitor cells. Cells were analyzed before (T0) and after 2 weeks in the presence (+T) or absence (−T) of trastuzumab. NTC indicates no template control. RN indicates reporter fluorescence normalized to internal control.
PII: S1083-8791(05)00425-8
doi: 10.1016/j.bbmt.2005.06.003
© 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 1
, Pages
68-74
, January 2006
